| |
|
|
|
Xtalks, Online
2025-11-11
The diagnosis of diabetes insipidus (DI) hinges on the careful assessment of the body’s ability to concentrate urine in response to water deprivation. Among the array of diagnostic tools available, osmolality testing plays a pivotal role in distinguishing central and nephrogenic DI from primary polydipsia and other causes of polyuria.
By systematically monitoring changes in serum and urine osmolality during the water deprivation test, clinicians can precisely evaluate renal concentrating capacity and antidiuretic hormone (ADH) responsiveness. This process not only enhances diagnostic specificity but also informs subsequent therapeutic strategies, ultimately leading to improved patient outcomes. The incorporation of osmolality measurements into water deprivation protocols ensures a robust, safe, evidence-based approach for the nuanced diagnosis of DI.
This webinar will guide attendees through the structured application of osmolality data during each phase of the water deprivation test. It will cover how clinicians interpret serum and urine values to determine when testing should proceed or stop, how urine concentration patterns inform diagnosis and how response to desmopressin provides critical clues for distinguishing underlying etiologies.
Register for this webinar to learn how osmolality testing supports the diagnosis and management of DI.
Keywords: Bioanalytical Testing, Diabetes, Diagnostic Test, Kidney, Laboratory Technology, Nephrology, Osmolality, Renal, Therapeutic Areas, Type 1 Diabetes, Type 2 Diabetes, Urine Test
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Dr. Arian Gower, MD, Nephrologist, Renal Consultants Medical Group
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2025-11-11
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|
|
|
|
|